Lmr Partners LLP Immunity Bio, Inc. Put Options Transaction History

Lmr Partners LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 07, 2024	SELL	$3.32 - $6.7 $545,144 - $1.1 Million	-164,200 Reduced 67.66%	78,500 $291,000
Q2 2024 Aug 14, 2024	BUY	$4.82 - $9.15 $794,818 - $1.51 Million	164,900 Added 211.95%	242,700 $1.53 Million
Q1 2024 May 15, 2024	SELL	$3.23 - $6.17 $15,181 - $28,999	-4,700 Reduced 5.7%	77,800 $417,000
Q4 2023 Feb 14, 2024	SELL	$1.25 - $5.21 $367,875 - $1.53 Million	-294,300 Reduced 78.11%	82,500 $414,000
Q3 2023 Nov 14, 2023	SELL	$1.29 - $3.1 $161,508 - $388,120	-125,200 Reduced 24.94%	376,800 $636,000
Q2 2023 Aug 14, 2023	BUY	$1.53 - $6.41 $768,060 - $3.22 Million	502,000 New	502,000 $1.4 Million

203

70M

1.65M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.22B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.